EndyMed Overview
EndyMed Medical is a medical technology company that designs, develops, and commercializes energy-based aesthetic treatment systems. The companys proprietary 3DEEP radio frequency technology is multisource and phase controlled, and provides a solution for fractional skin resurfacing, wrinkle treatment, scar treatment, skin tightening, and body contouring.
Cumulative Funding Raised Over Time ($)
$7.0MAug 2014
Latest News
growth-positive
/PRNewswire/ -- ENDYMED Ltd ("ENDYMED"), is proud to announce the successful completion of its full merger with its majority shareholder Shanghai Haohai...
ENDYMED Ltd has successfully completed a full merger with its majority shareholder, Shanghai Haohai Biological Technology Co., Ltd. This strategic consolidation aims to strengthen ENDYMEDs presence in the Chinese market and enhance its global reach. The merger provides ENDYMED with increased strategic flexibility, expanded resources, and enhanced decision-making capabilities. The unified structure is expected to streamline the global supply chain, accelerate innovation, and strengthen the companys position in key international markets. ENDYMEDs FDA-cleared 3DEEP® RF technology continues to be a leader in energy-based aesthetic treatment systems, offering solutions for skin rejuvenation and other treatments.
Acquired-by
growth-positive
A Chinese social media influencer sold approximately $ 1 million worth of Endymed's home use products within minutes
Endymed, a medical-aesthetic device company, announced a successful online marketing broadcast in China where its home use device, NEWA, was sold for approximately $1 million. The companys distributor in China entered into a cooperation agreement with a social media influencer, resulting in the sale of the home use products. Over TMALL, $1 million worth of products were sold, and NEWA ranked first in sales on the platform. The distributor intends to continue the cooperation with the influencer. Endymed develops and sells medical-aesthetic devices for rejuvenating and firming the skin. They have a product line for professionals and a consumer market line.
Customers
growth-positive
ENDYMED Medical Releases the FSR Fractional Skin Resurfacing Treatment Applicator in the US Market
ENDYMED Medical Ltd has released its FSR Fractional Skin Resurfacing handpiece in the USA. The handpiece combines Smooth Scanning fractional ablation with 3DEEP deep volumetric heating, providing skin resurfacing and rejuvenation, wrinkle reduction, tightening, and scar reduction treatments. The FSR handpiece has an energy penetration depth of 2.9mm and works well in delicate-skin areas. It offers customizable parameters and can be used in combination with other ENDYMED handpieces for exceptional results. ENDYMED Medical offers energy-based medical aesthetic treatment systems for both professional and consumer markets, using their proprietary 3DEEP radiofrequency technology.
Customers
https://www.palmbeachdailynews.com/marketing/new-technology-improves-wrinkles-and-tightens-skin/ZeGuVi8DSxdsvvFUe3MbQL/
growth-positive
The New Non-Surgical Celebrity Facelift That You Can Get Too
The article discusses the Endymed Intensif procedure, a non-invasive anti-aging treatment that stimulates collagen production. The procedure is successful in tightening and lifting various areas of the face and neck. It is also effective in treating acne scars. The treatment is considered a more affordable alternative to surgical facelifts. The article encourages readers to find a trained dermatologist through Castle Connolly Top Doctors. The impact on the company is growth-positive as more women are opting for this procedure instead of surgery.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $7M |
| Last funding | $7M |
| Stage | Public |
| Rounds | 2 |
| Investors | 1 |
Team Members
4
Employees: 51-200
Web & Social Links
| Website | endymed.com |
| Careers | Careers page |
Locations
Leshem Industrial Park Street 12, Caesarea, Israel
4400 Route 9, Freehold Township, NJ, USA
Photos & Videos
3 item(s)
EndyMed Business
Business models
B2B2C
Product stage
Released
Employees
51-200
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyCosmetic MaterialsMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersLife SciencesCosmeticsCommerce & RetailDistribution ChannelsDistributorCore Technology
CommunicationsRadio FrequencyTags (13)
skin-caredermatologycosmeticsanti-agingrf-technologynon-surgicalnon-invasiveacnepatientsmedical-devicestreatmentswellnessclinicsGeographic Markets
South KoreaEuropeUnited StatesIsraelHong KongEndyMed Financials
$7M
Total funding
Undisclosed
Capital raised
$7M
Last funding
Public
Funding stage
2
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$7.0MAug 2014
Private Equity Funding
PIPE
Aug 2014
$7M
OHMK Medical Technology
Public Offering / Exit
POEvent
Jan 2007
Undisclosed
EndyMed Lifecycle
Cumulative Funding Raised Over Time
$7.0MAug 2014
All Events
PIPE
Aug 2014
$7M
OHMK Medical Technology
POEvent
Jan 2007
Undisclosed
EndyMed News
8 articles
growth-positive
/PRNewswire/ -- ENDYMED Ltd ("ENDYMED"), is proud to announce the successful completion of its full merger with its majority shareholder Shanghai Haohai...
ENDYMED Ltd has successfully completed a full merger with its majority shareholder, Shanghai Haohai Biological Technology Co., Ltd. This strategic consolidation aims to strengthen ENDYMEDs presence in the Chinese market and enhance its global reach. The merger provides ENDYMED with increased strategic flexibility, expanded resources, and enhanced decision-making capabilities. The unified structure is expected to streamline the global supply chain, accelerate innovation, and strengthen the companys position in key international markets. ENDYMEDs FDA-cleared 3DEEP® RF technology continues to be a leader in energy-based aesthetic treatment systems, offering solutions for skin rejuvenation and other treatments.
Acquired-by
growth-positive
A Chinese social media influencer sold approximately $ 1 million worth of Endymed's home use products within minutes
Endymed, a medical-aesthetic device company, announced a successful online marketing broadcast in China where its home use device, NEWA, was sold for approximately $1 million. The companys distributor in China entered into a cooperation agreement with a social media influencer, resulting in the sale of the home use products. Over TMALL, $1 million worth of products were sold, and NEWA ranked first in sales on the platform. The distributor intends to continue the cooperation with the influencer. Endymed develops and sells medical-aesthetic devices for rejuvenating and firming the skin. They have a product line for professionals and a consumer market line.
Customers
growth-positive
ENDYMED Medical Releases the FSR Fractional Skin Resurfacing Treatment Applicator in the US Market
ENDYMED Medical Ltd has released its FSR Fractional Skin Resurfacing handpiece in the USA. The handpiece combines Smooth Scanning fractional ablation with 3DEEP deep volumetric heating, providing skin resurfacing and rejuvenation, wrinkle reduction, tightening, and scar reduction treatments. The FSR handpiece has an energy penetration depth of 2.9mm and works well in delicate-skin areas. It offers customizable parameters and can be used in combination with other ENDYMED handpieces for exceptional results. ENDYMED Medical offers energy-based medical aesthetic treatment systems for both professional and consumer markets, using their proprietary 3DEEP radiofrequency technology.
Customers
https://www.palmbeachdailynews.com/marketing/new-technology-improves-wrinkles-and-tightens-skin/ZeGuVi8DSxdsvvFUe3MbQL/
growth-positive
The New Non-Surgical Celebrity Facelift That You Can Get Too
The article discusses the Endymed Intensif procedure, a non-invasive anti-aging treatment that stimulates collagen production. The procedure is successful in tightening and lifting various areas of the face and neck. It is also effective in treating acne scars. The treatment is considered a more affordable alternative to surgical facelifts. The article encourages readers to find a trained dermatologist through Castle Connolly Top Doctors. The impact on the company is growth-positive as more women are opting for this procedure instead of surgery.
Customers
growth-positive
EndyMed Launches At-Home Radio Frequency Antiaging Device
EndyMed is launching a mini-version of a doctor’s office treatment as a take-home device called the Newa. The Newa uses EndyMed Professional 3Deep technology to stimulate collagen production for tighter and younger-looking skin. It will be available at Bergdorf Goodman and Neiman Marcus for $450. The product is expected to roll into stores in early 2017. The Newa has already been sold in select markets outside the U.S. and sold out 400 units on QVC in Germany in the first 30 minutes. In the long-term, industry sources expect the business could grow to as much as $100 million in sales.
Customers
growth-positive
EndyMed signs distribution agreement in S Korea
EndyMed has signed a distribution agreement in South Korea for its Newa Skin Care System home-use wrinkle reduction device. The agreement is worth a minimum of $2.5 million over two years. EndyMeds share price rose 3.16% on the Tel Aviv Stock Exchange. The company recorded revenue of $13.6 million in 2015.
Customers
growth-positive
EndyMed raises $7m from Chinese distributor
EndyMed Ltd. has completed an agreement with Chinese company OHMK Medical Technology, which will acquire a 37.21% stake in the company. OHMK markets EndyMeds products in China after obtaining approval from the China Food and Drug Administration. The Chinese company also has an option to invest an additional $1 million. EndyMed CEO sees this as a vote of confidence and states that the company is experiencing consistent growth in sales and expanding into new territories and markets.
Partners
EndyMed Team
Employee Info
| Employees (range) | 51-200 |
| Exact count | 54 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 16 classification IDs that could be used for matching.
EndyMed Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 93/100 |
| Missing | markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 513927236 |
| Crunchbase | endymed-medical |
| Phone | +97246309100 |
| Creator | Jenny Sotnik-Talisman |
| Creator email | genys30@yahoo.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-11-23T00:00:00.000Z |
| Created | 2014-08-10T00:00:00.000Z |
| Status detail | Public on TASE on Jan, 2007; |